# FMC Corp: Form 10-Q for the period ended Jun 30, 2012

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2012-08-01
- Accepted by EDGAR: Aug 1, 2012, 15:43 ET
- Period: 2012-06-30
- Accession: 0000037785-12-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778512000019/fmc630201210q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778512000019/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2012-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2012-04-01 to 2012-06-30 | $905.2m | us-gaap:Revenues |
| Revenue | 6 months, 2012-01-01 to 2012-06-30 | $1.85bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2012-04-01 to 2012-06-30 | $567.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months, 2012-01-01 to 2012-06-30 | $1.16bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2012-04-01 to 2012-06-30 | $337.8m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2012-01-01 to 2012-06-30 | $685.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2012-04-01 to 2012-06-30 | $128.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2012-01-01 to 2012-06-30 | $257.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2012-04-01 to 2012-06-30 | $175.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2012-01-01 to 2012-06-30 | $363.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2012-04-01 to 2012-06-30 | $45.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2012-01-01 to 2012-06-30 | $90.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2012-04-01 to 2012-06-30 | $104.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2012-01-01 to 2012-06-30 | $224.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2012-04-01 to 2012-06-30 | $0.76 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2012-01-01 to 2012-06-30 | $1.61 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2012-04-01 to 2012-06-30 | $0.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2012-01-01 to 2012-06-30 | $1.62 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2012-04-01 to 2012-06-30 | 138,253,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2012-01-01 to 2012-06-30 | 138,991,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2012-01-01 to 2012-06-30 | $267.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2012-01-01 to 2012-06-30 | $81.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months, 2012-01-01 to 2012-06-30 | $22.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months, 2012-01-01 to 2012-06-30 | $144.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2012-06-30 | $75.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2012-06-30 | $1.95bn | us-gaap:AssetsCurrent |
| Total assets | at 2012-06-30 | $3.91bn | us-gaap:Assets |
| Current liabilities | at 2012-06-30 | $996.4m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2012-06-30 | $810.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2012-06-30 | $4.9m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2012-06-30 | $1.32bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2012-06-30 | 137,317,914 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 58,561 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2011 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2011 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2011 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and lithium businesses. This segment focuses on food ingredients that are used to enhance texture, color, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium for energy storage, specialty polymers and pharmaceutical synthesis. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens, zeolites and silicates. This segment serves a diverse group of markets, from economically-sensitive industrial sectors to technology-intensive specialty markets. The products in this segment are sought by customers for their critical reactivity or specific functionality in markets such as glass, detergents, chemicals and pulp and paper.

### Second Quarter 2012 Highlights

Our businesses continue to experience positive results primarily from higher volumes and higher pricing. Results for the three months ended June 30, 2012, reflect increases in both consolidated revenues and earnings driven by solid performance.

The following are the more significant developments in our businesses during the three months ended June 30, 2012:

- Revenue of $905.2 million for the three months ended June 30, 2012 increased $93 million or 11 percent versus the same period last year. Included in this increase was approximately $20 million associated with recently completed acquisitions. Revenue increased in all businesses. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in Asia were up 13 percent, sales in Latin America grew 32 percent, sales in North America were up 9 percent while sales in Europe, Middle East and Africa decreased slightly by 4 percent.
- Our gross margin, excluding acquisition-related charges, increased by $42.2 million or approximately 14 percent to $341.0 million versus last year's second quarter. Gross margin percent of 38 percent increased approximately one percent, driven by higher selling prices and improved mix partially offset by higher costs.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges, increased approximately $15 million or 14 percent to $119.2 million, largely due to increased spending on targeted growth initiatives and to meet the growth in our business. The majority of these increases were experienced in our Agricultural Products segment.
- Research and Development expenses of $28.4 million increased $3.4 million or 14 percent, largely due to increased spending in Agricultural Products associated with various innovation projects.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $126.9 million increased $16.4 million or 15 percent primarily due to higher operating results in Agricultural Products and Industrial Chemicals. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
- We also completed the following growth initiatives:
- In June 2012, we acquired Phytone Ltd (Phytone). Phytone is a natural colors producer based in the United Kingdom. Phytone's natural products and formulations are used by global customers in the food, beverage, personal care and nutrition sectors. Phytone will be consolidated into our existing BioPolymer division within our Specialty Chemicals segment.
- In July 2012, we entered into an agreement to acquire Pectine Italia. This acquisition will enable us to enter the pectin market which complements our portfolio of texturant product lines which is part of our BioPolymer division within our Specialty Chemicals segment. This acquisition is expected to close by the end of the third quarter 2012.
- In July 2012, we made the decision to invest more than $100 million in a new world class microcrystalline cellulose (MCC) manufacturing facility in Rayong, Thailand. The new plant will ensure our long-term ability to supply the growing Asia market with our industry leading Avicel colloidal MCC which is part of our BioPolymer division within our Specialty Chemicals segment.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2012 Revenue | Three Months Ended June 30 | 2011 | Six Months Ended June 30 2012 | 2011 |
| --- | ---: | ---: | ---: | ---: |
| Agricultural Products | $393.6 | $329.6 | $847.8 | $673.2 |
| Specialty Chemicals | 235.4 | 228.5 | 451.3 | 438.6 |
| Industrial Chemicals | 277.1 | 254.8 | 549.7 | 497.3 |
| Eliminations | (0.9) | (0.7) | (2.9) | (1.9) |
| Total | $905.2 | $812.2 | $1,845.9 | $1,607.2 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| Agricultural Products | $111.2 | $94.3 | $241.0 | $194.8 |
| Specialty Chemicals | 52.7 | 56.0 | 97.0 | 100.9 |
| Industrial Chemicals | 42.8 | 36.2 | 90.9 | 76.5 |
| Eliminations | — | 0.1 | — | — |
| **Segment operating profit** | 206.7 | 186.6 | $428.9 | $372.2 |
| Corporate | (14.7) | (15.6) | (28.9) | (32.4) |
| Other income (expense), net (1) | (4.3) | (4.9) | (15.5) | (12.2) |
| Operating profit before the items listed below (2) | 187.7 | 166.1 | 384.5 | 327.6 |
| Interest expense, net | (11.5) | (10.5) | (22.8) | (20.4) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income | (5.6) | (9.3) | (7.3) | (13.8) |
| Non-operating pension and postretirement charges (3) | (9.1) | (4.5) | (18.2) | (9.0) |
| Acquisition-related charges | (3.2) | — | (6.6) | — |
| Provision for income taxes | (45.3) | (25.7) | (90.1) | (66.3) |
| Discontinued operations, net of income taxes | (8.1) | (8.9) | (15.5) | (16.9) |
| **Net income attributable to FMC stockholders** | $104.9 | $107.2 | $224.0 | $201.2 |

(1) Other income (expense), net is comprised primarily of last-in first-out (“LIFO”) inventory adjustments and certain employee benefits, including incentive compensation. Our business segments account for their inventory utilizing a first-in first-out ("FIFO") basis of accounting. The LIFO inventory adjustments are not allocated to the business segments and therefore are recorded to "Other income (expense), net".

(2) Results for all segments including corporate expense and other income (expense) are net of noncontrolling interest of $5.4 million and $5.0 million for the three months ended June 30, 2012 and 2011 and $10.9 million and $8.4 million for the six months ended June 30, 2012 and 2011, respectively. The majority of the noncontrolling interest pertains to our Industrial Chemicals segment.

(3) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, acquisition-related charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2012 | Three Months Ended June 30 | 2011 | Six Months Ended June 30 2012 | 2011 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $104.9 | $107.2 | $224.0 | $201.2 |
| Corporate special charges (income), pre-tax | 17.9 | 13.8 | 32.1 | 22.8 |
| Income tax expense (benefit) on Corporate special charges (income) | (6.4) | (4.6) | (11.7) | (7.7) |
| Corporate special charges (income), net of income taxes | 11.5 | 9.2 | 20.4 | 15.1 |
| Discontinued operations, net of income taxes | 8.1 | 8.9 | 15.5 | 16.9 |
| Tax adjustments | 2.4 | (14.8) | 2.4 | (15.1) |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $126.9 | $110.5 | $262.3 | $218.1 |

### Three months ended June 30, 2012 compared to three months ended June 30, 2011

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition-related charges, and other income and expense items.

Information about how some of these items relate to our businesses at the segment level is discussed in Note 18 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2011 consolidated financial statements in our 2011 10-K.

### Agricultural Products

*(in Millions)*

| 2012 | Three Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $393.6 | $329.6 | $64.0 | 19% |
| Operating Profit | 111.2 | 94.3 | 16.9 | 18 |

Revenue of $393.6 million increased approximately 19 percent versus the prior year quarter due to strong sales in Latin America and North America, offset by a slight decline in Asia and Europe/Middle East/Africa ("EMEA"). Revenue for the three months ended June 30, 2012 included approximately $12 million associated with acquisitions closed in the second half of 2011.

Revenue in Latin America of $151.8 million increased 36 percent reflecting continued strong demand in sugarcane, growth in soybean markets and sales from our joint venture, Ruralco, in Argentina which we acquired in 2011. Sales in North America of $119.1 million increased 29 percent driven by strong demand for our proprietary herbicides and higher insecticide sales. Revenue in Asia of $67.3 million decreased one percent and sales in EMEA of $55.5 million decreased three percent versus the prior period.

Agricultural Products' operating profit of $111.2 million increased approximately 18 percent compared to the year-ago quarter, reflecting the preceding paragraph's sales growth partially offset by a $12 million increase in selling, general and administrative costs mainly for focused growth initiatives and to support growth in the business. In addition, segment earnings were also impacted by higher research and development costs of $3.5 million due to higher spending associated with various innovation projects.

### Specialty Chemicals

*(in Millions)*

| 2012 | Three Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $235.4 | $228.5 | $6.9 | 3% |
| Operating Profit | 52.7 | 56.0 | (3.3) | (6) |

Revenue in Specialty Chemicals was $235.4 million, an increase of approximately three percent versus the prior-year quarter. The increase was driven primarily by higher selling prices across the segment, particularly in food and lithium primaries markets. Revenue for the three months ended June 30, 2012 included approximately $3 million associated with recently completed acquisitions.

BioPolymer revenue of $174.4 million increased approximately three percent from the prior-year quarter. This increase was due to favorable pricing which increased sales by five percent and revenue from acquisitions which increased sales by one percent. These increases were partially offset by unfavorable currency impacts, primarily due to the weaker Euro, which decreased sales by three percent.

Lithium revenue of $61.0 million increased approximately four percent compared to the prior-year quarter. This increase was due to higher pricing which impacted sales by five percent partially offset by unfavorable currency impacts of one percent. Lithium sales growth was led by higher selling prices in lithium primaries. Lithium continues to be impacted by tightening of supply and the lingering impacts of operational issues faced in the first quarter of 2012 which has keep volumes flat.

Segment operating profit of $52.7 million decreased by six percent versus the year ago quarter. Higher prices in both BioPolymer and Lithium were more than offset by the lingering effects of higher manufacturing costs and weather-related operating impacts at our Argentina lithium facility as well as higher raw material costs in BioPolymer and unfavorable exchange rate impacts. Selling, general and administrative expenses also increased by $3.5 million to support growth initiatives primarily in BioPolymer related to increased investment to support growth initiatives such as the natural colors effort.

### Industrial Chemicals

*(in Millions)*

| 2012 | Three Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $277.1 | $254.8 | $22.3 | 9% |
| Operating Profit | 42.8 | 36.2 | 6.6 | 18 |

Revenue in Industrial Chemicals was $277.1 million, an increase of approximately nine percent versus the prior-year quarter. Revenue increased due to higher pricing across the segment of six percent, higher volumes of two percent, the impact of acquisitions completed in the second half of 2011 of two percent offset by a one percent decrease due to unfavorable currency impacts.

Alkali revenues of $189.3 million were up 13 percent due to higher pricing particularly in the export market and higher volumes. Volume growth was partially related to production at our Granger facility which came on line in the middle of last year. Export demand continues to be robust, especially in Asia and Latin America.

The segment also experienced increased pricing in our Peroxygens division, where quarter revenues increased by one percent to $87.8 million. The increased pricing was primarily in our hydrogen peroxide and specialty peroxygens product lines.

Segment operating profit of $42.8 million increased approximately 18 percent versus the year ago quarter primarily as a result of the higher pricing and volumes experienced in both Alkali and Peroxygens as well as the continued favorable mix shift in

Peroxygens toward specialties applications. Partially offsetting the favorable pricing were higher royalty and manufacturing costs associated with our operations near Green River, Wyoming.

### Other Results of Operations

#### Corporate expenses

Corporate expenses of $14.7 million in the second quarter of 2012 decreased slightly $0.9 million from $15.6 million. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other expense decreased slightly to $4.3 million in the second quarter of 2012 from $4.9 million in the same period of 2011. Other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the second quarter of 2012 was $11.5 million as compared to the second quarter of 2011 of $10.5 million. The increase was primarily due to higher debt levels associated with the issuance of our 3.95% senior notes during the 4th quarter of 2011. The interest expense on these notes was $3.0 million in the second quarter of 2012. The higher interest associated with our senior notes was slightly offset by a decrease in our foreign debt interest expense during the quarter ended June 30, 2012 as compared to 2011 of approximately $2.1 million.

#### Corporate special (charges) income

#### Restructuring and other charges (income)

These charges totaled $5.6 million in the second quarter of 2012 compared to $9.3 million in the second quarter of 2011. Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income). Please see the table and further discussion regarding our restructuring and other charges (income) in Note 8 to our condensed consolidated financial statements included in this Form 10-Q. Restructuring and asset disposal charges in 2012 of $4.3 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $1.3 million was primarily associated with charges for environmental remediation at operating sites.

Restructuring and asset disposal charges of $6.4 million in 2011 were primarily associated with charges associated with our Sodium Percarbonate shutdown which began in the second quarter of 2011. Other charges (income) net in 2011 of $2.9 million was primarily associated with charges for environmental remediation at operating sites.

The liabilities associated with the restructuring charges listed above are also included within Note 8 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended June 30, 2012 was $9.1 million compared to $4.5 million for the three months ended June 30, 2011. The increase in charges was primarily the result of higher amortization impacts of actuarial losses of $4.0 million. These expenses are included as a component of the line item "Selling, general and administrative expenses" on our condensed consolidated statements of income.

#### Acquisition-related charges

The charge for the three months ended June 30, 2012 of $3.2 million is related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with recently completed acquisitions. On the condensed consolidated statements of income, these charges are included in “Costs of sales and services”. No such charges occurred for the three months ended June 30, 2011. See Note 3 to our condensed consolidated financial statements included in this Form 10-Q for more information on our acquisitions.

#### Provision for income taxes

Provision for income taxes was $45.3 million for the second quarter of 2012 compared to a provision of $25.7 million for the prior year period resulting in effective tax rates of 27.7 percent and 17.5 percent, respectively. The increase in the effective tax rate is primarily a result of a reduction recorded in 2011 in our liability for unrecognized tax benefits of approximately $14.1 million as a result of settlements of audits. The remaining change represents the mix of income earned in various tax jurisdictions.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued prior to 2002. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a charge of $8.1 million for the three months ended June 30, 2012, compared to a charge of $8.9 million for the three months ended June 30, 2011. The charge for the three months ended June 30, 2012 and 2011, was primarily related to charges for legal reserves and expenses related to discontinued operations and an increase in our reserves for operating and maintenance activities for a number of environmental sites.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders decreased to $104.9 million for the three months ended June 30, 2012, from $107.2 million for the three months ended June 30, 2011. This change was primarily a result of higher interest expense, non-operating pension and postretirement charges, acquisition-related charges and a higher effective tax rate. These additional costs were partially offset by higher operating profits in Agricultural Products and Industrial Chemicals and reduced restructuring and other charges.

### Six months ended June 30, 2012 compared to six months ended June 30, 2011

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Agricultural Products

*(in Millions)*

| 2012 | Six Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $847.8 | $673.2 | $174.6 | 26% |
| Operating Profit | 241.0 | 194.8 | 46.2 | 24 |

Revenue of $847.8 million increased approximately 26 percent versus the prior year period as sales gains were achieved in all regions. Revenue for the six months ended June 30, 2012 included approximately $28 million associated with acquisitions that closed in the second half of 2011.

Sales in North America improved 30 percent to $272.1 million reflecting favorable market conditions and strong demand for our proprietary herbicides and insecticides and growth from new or recently introduced products. Latin America revenue of $344.8 million increased 40 percent reflecting a strong finish to the crop season in Brazil driven by key crops such as sugarcane, cotton and soybeans and sales from our new market access joint venture, Ruralco, in Argentina. Revenue in Asia of $139.5 million increased eight percent as a result of growth in newly-launched and acquired products. Sales in Europe, Middle East and Africa (EMEA) of $91.3 million increased four percent due to higher insecticide and fungicide volumes.

Agricultural Products' operating profit of 241.0 million increased approximately 24 percent compared to the six months ended June 30, 2011, reflecting the broad-based sales growth partially offset by a $27.3 million increase in selling, general and administrative costs mainly for focused growth initiatives and to support the higher year-to-date sales. In addition, segment earnings were also impacted by higher research and development costs of $9.2 million due to increased spending associated with various innovation projects.

In 2012, we expect full-year revenue growth in the high teens reflecting increased volumes in all regions, particularly in Latin America, North America and Asia, due to anticipated strong market conditions and growth from new and acquired products. We expect full-year segment operating profit growth in the high teens driven by the sales gains partially offset by higher spending on targeted growth initiatives.

#### Certain Regulatory Issues

In the European Union ("EU"), following an administrative appeals process, the European Commission's proposal to exclude our bifenthrin product from the European Commission's official list of approved pesticides, was adopted on November 30,

2009\. FMC had an additional six months to sell bifenthrin in the EU, through May 2010, and subsequently, in most EU countries, there was up to 6-12 months for further sale by distributors or dealers, and use by farmers. On December 30, 2010, the French Ministry of Agriculture issued a notice adding bifenthrin, along with eight other pesticidal active ingredients, to the “Grenelle” list of pesticides. We believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we are challenging the decision. At the European level, we re-submitted for reconsideration. The European Commission has reviewed the re-consideration dossier and, in December 2011, issued its recommendation that bifenthrin be included on the approved product list. During the second quarter 2012, bifenthrin was re-approved for use in the European Union. FMC will now re-submit for registrations in EU Member States. We can resume selling bifenthrin in the European market once the registrations are approved by the Member States. We expect that most registrations will be approved over the next 24 months. During 2012, however, we will not sell any bifenthrin for agricultural use into the EU, similar to the prior year, and the absence of such sales will not have a material effect on the Company's financial condition or results of operations.

We intend to defend vigorously all our products in the U.S., EU and other countries' regulatory processes where FMC's pesticide products will be reviewed in the ordinary course of regulatory programs during 2012 as part of the ongoing cycle of re-registration in countries around the world. In 2008, the Brazilian health surveillance agency informed us that they intend to review carbofuran along with 13 other major pesticides, but has yet to issue any required formal announcement that identifies their specific concerns or preliminary position on re-registration. We are cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to regulatory reviews in Brazil during 2012.

### Specialty Chemicals

*(in Millions)*

| 2012 | Six Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $451.3 | $438.6 | $12.7 | 3% |
| Operating Profit | 97.0 | 100.9 | (3.9) | (4) |

Revenue in Specialty Chemicals was $451.3 million, an increase of approximately three percent versus the prior year period. The increase was driven primarily by higher selling prices across the segment, particularly in food, pharmaceuticals and lithium primaries markets. Revenue for the six months ended June 30, 2012 included approximately $4 million associated with recently completed acquisitions.

BioPolymer revenue of $339.0 million increased approximately three percent from the six months ended June 30, 2011. This increase was due to favorable pricing which impacted sales by seven percent and revenue from acquisitions which increased sales by one percent. These increases were partially offset by decreased volumes of three percent and unfavorable currency impacts of two percent.

Lithium revenue of $112.3 million increased approximately three percent compared to the prior year. This increase was due to higher pricing which impacted sales by six percent partially offset by decreased volumes and unfavorable currency impacts which decreased sales by two percent and one percent, respectively. Lithium sales growth was led by higher selling prices in lithium primaries. Lithium continues to be impacted by tightening of supply which has impacted volumes. Lower volumes also resulted from production downtime in the first quarter of 2012, associated with our capacity expansion in Argentina, as well as the lingering effect of related operational issues.

Segment operating profit of $97.0 million decreased slightly by four percent versus the year ago period. Higher pricing in both BioPolymer and lithium were more than offset by higher raw material and manufacturing costs in BioPolymer and higher manufacturing costs and weather-related operating impacts at our Argentina lithium facility. The higher manufacturing costs in the segment were partially associated with capacity expansions in both lithium and BioPolymer as we position both businesses for enhanced growth. Selling, general and administrative expenses also increased by $7.1 million to support growth initiatives, primarily in BioPolymer.

In 2012, we expect full-year revenue growth of approximately five percent driven by higher selling prices across the segment and volume growth in BioPolymer. Full-year segment operating profit is expected to be flat with sales gains offset by the impacts of operational issues and continuing cost increases in Argentina in lithium, as well as higher raw material costs and higher spending on targeted growth initiatives in BioPolymer.

### Industrial Chemicals

*(in Millions)*

| 2012 | Six Months Ended June 30 | 2011 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $549.7 | $497.3 | $52.4 | 11% |
| Operating Profit | 90.9 | 76.5 | 14.4 | 19 |

Revenue in Industrial Chemicals was $549.7 million, an increase of approximately 11 percent versus the prior-year period. Revenue increased due to higher pricing across the segment of six percent, higher volumes of three percent, and impact of acquisitions completed in the second half of 2011 of two percent.

Alkali revenues of $376.0 million were up 15 percent due to higher pricing particularly in the export market and higher volumes. Volume growth was partially related to full production at our Granger facility which came on line in the middle of last year. Export demand continues to be robust, especially in Asia and Latin America.

The segment also experienced increased pricing in our Peroxygens division, where quarter revenues increased by three percent to $173.7 million. The increased pricing was primarily in our hydrogen peroxide and specialty peroxygens product lines.

Segment operating profit of $90.9 million increased approximately 19 percent versus the year ago quarter primarily as a result of the higher pricing and volumes experienced in Alkali and Peroxygens as well as the continued favorable mix shift in Peroxygens toward specialties applications. Partially offsetting the favorable pricing were higher royalty and energy costs associated with our operations near Green River, Wyoming.

In 2012, we expect full-year revenue to be up in the mid-to-high single digits due to higher selling prices and volume gains in soda ash and specialty peroxygens. We expect full-year operating profit growth in the high teens, driven by higher sales and continued mix shift toward specialty peroxygens.

#### Venezuela Investment

Recent events in Venezuela, such as hyperinflation, devaluation of currency, government price controls, parallel exchange rates, and political issues have created significant risks and uncertainties for the Venezuelan subsidiaries of multinational corporations. We hold a noncontrolling investment in a Venezuelan phosphate business, Tripoliven C.A. The value of this investment on our consolidated balance sheet at June 30, 2012 is approximately $9 million. While there has been a lag between the declaration and payment to us of dividends from Tripoliven, we did receive dividends from Tripoliven during 2010. We do not believe there is any impairment of Tripoliven at June 30, 2012, as Tripoliven has operated as a profitable business and we expect in the future to recover at least the value of our investment. If our investment in Tripoliven were to be impaired, it would have an immaterial impact on our liquidity and consolidated financial position, but the impairment charge would have a one-time effect on our results of operations in the period in which it would be recorded.

### Other Results of Operations

#### Corporate expenses

Corporate expenses of $28.9 million for the six months ended June 30, 2012 decreased $3.5 million from $32.4 million. The decrease is primarily driven by consulting expenses of $4.1 million incurred during the first quarter of 2011 as a result of our global procurement initiative, aimed at reducing the costs of goods and services purchased on a world-wide basis. These consulting expenses did not repeat during 2012.

#### Other income (expense), net

Other expense increased to $15.5 million in the six months ended June 30, 2012 from $12.2 million in the same period of 2011. The amount in 2012 was impacted by a period over period increase in our LIFO inventory reserve of $2.2 million. Additionally, the increase from 2011 to 2012 was driven by employee incentive costs of $1.5 million mainly for focused growth initiatives in the business.

#### Interest expense, net

Interest expense, net for the first six months of 2012 was $22.8 million as compared to the same period of 2011 of $20.4 million. The increase was primarily due to higher debt levels associated with the issuance of our 3.95% senior notes during the 4th quarter of 2011. The interest expense on these notes was $6.0 million in the first six months of 2012. The higher interest associated with our senior notes was slightly offset by a decrease in our foreign debt interest expense during the six month period ended June 30, 2012 as compared to 2011 of approximately $3.5 million.

#### Corporate special (charges) income

#### Restructuring and other charges (income)

These charges totaled $7.3 million in the six months ended June 30, 2012 compared to $13.8 million for the same period of 2011. Restructuring and asset disposal charges in 2012 of $5.4 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $1.9 million was primarily associated with charges for environmental remediation at operating sites.

Restructuring and asset disposal charges of $9.2 million in 2011 primarily represent charges associated with our Sodium Percarbonate shutdown which began in the second quarter of 2011. Other charges (income) net in 2011 of $4.6 million were primarily associated with charges for environmental remediation at operating sites.

#### Non-operating pension and postretirement charges

The charge for the six months ended June 30, 2012 was $18.2 million compared to $9.0 million for the six months ended June 30, 2011. The increased charge was primarily the result of higher amortization impacts of actuarial losses of $8.0 million.

#### Acquisition-related charges

The charge for the six months ended June 30, 2012 of $6.6 million was related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with recently completed acquisitions.

#### Provision for income taxes

Provision for income taxes was $90.1 million for the first six months of 2012 compared to a provision of $66.3 million for the prior year period resulting in effective tax rates of 26.5 percent and 22.6 percent, respectively. The increase in the effective tax rate was primarily the result of a reduction recorded in 2011 in our liability for unrecognized tax benefits of approximately $14.1 million as a result of settlements of audits. The remaining change represents the mix of income earned in various tax jurisdictions.

#### Discontinued operations, net of income taxes

Discontinued operations, net of income taxes totaled a charge of $15.5 million for the six months ended June 30, 2012, compared to a charge of $16.9 million for the six months ended June 30, 2011. The charges for 2012 and 2011 were primarily related to charges for legal reserves and expenses related to discontinued operations and an increase in our reserves for operating and maintenance activities for a number of environmental sites.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $224.0 million for the six months ended June 30, 2012, from $201.2 million for the six months ended June 30, 2011. The increase was primarily due to higher operating profits in Agricultural Products and Industrial Chemicals and decreased restructuring and other charges. These items were partially offset by the increase in interest expense, non-operating pension and postretirement charges, acquisition-related charges and a higher effective tax rate.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at June 30, 2012 and December 31, 2011, were $75.5 million and $158.9 million, respectively. Of the cash and cash equivalents balance at June 30, 2012, $60.6 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings. In the event that funds from our foreign subsidiaries are repatriated to the U.S., we would be required to accrue and pay U.S. taxes on those amounts.

At June 30, 2012, we had total debt of $856.5 million as compared to $825.6 million at December 31, 2011. The increase was primarily associated with higher borrowings under our committed credit facility to support working capital requirements. Total debt included $810.0 million and $779.1 million of long-term debt (excluding current portions of $4.9 million and $19.5 million) at June 30, 2012 and December 31, 2011, respectively. Short-term debt, which consists solely of foreign borrowings, increased from $27.0 million at December 31, 2011 to $41.6 million at June 30, 2012.

### Statement of Cash Flows

*Cash provided by operating activities was $267.9 million and $163.0 million for the first six months of 2012 and 2011, respectively.*

The table below presents the components of net cash provided (required) by operating activities.

*(in Millions)*

| 2012 | Six Months Ended June 30 | 2011 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $363.5 | $310.6 |
| Significant non-cash expenses (1) | 108.1 | 93.0 |
| **Operating income before non-cash expenses (Non-GAAP)** | **471.6** | **403.6** |
| Change in trade receivables (2) | (64.1) | 3.4 |
| Change in inventories (3) | (90.7) | (63.6) |
| Change in accounts payable (4) | (87.5) | (75.2) |
| Change in accrued rebates (5) | 142.9 | 80.5 |
| Change in all other operating assets and liabilities (6) | (21.7) | (59.0) |
| Restructuring and other spending (7) | (5.4) | (33.2) |
| Environmental spending, continuing, net of recoveries (8) | (2.3) | (4.2) |
| Pension and other postretirement benefit contributions (9) | (33.2) | (41.6) |
| **Cash basis operating income (Non-GAAP)** | **309.6** | **210.7** |
| Interest payments | (13.5) | (19.4) |
| Tax payments | (22.0) | (23.1) |
| Excess tax benefits from share-based compensation | (6.2) | (5.2) |
| **Cash provided by operating activities** | **$267.9** | **$163.0** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) Overall, the use of cash for trade receivables is primarily due to revenue increases, particularly for Agricultural Products' sales in Brazil where terms are significantly longer than the rest of our businesses. Receivable collections improved in 2012 in relation to the increase in 2012 revenue.

(3) The change in inventory from 2011 to 2012 resulted in a use of cash primarily due to an inventory build to fulfill projected 2012 demand in Agricultural Products and in Specialty Chemicals' BioPolymer division.

(4) The increased cash outflow in 2012 was driven by the inventory build at the end of 2011 to satisfy projected demand, which was paid during the first quarter 2012.

(5) These rebates are associated with our Agricultural Products segment and are primarily in North America and Brazil and generally settle in the fourth quarter of each year. The increase from 2011 to 2012 is primarily associated with the increased sales for Agricultural Products in North America.

(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities.

(7) See Note 8 in our condensed consolidated financial statements included in this Form 10-Q for further details. The higher payments in 2011 was primarily associated with the exit of the phosphate business at our Huelva, Spain facility at the end of 2010.

(8) Included in our income for both periods presented are environmental charges of $2.5 million and $3.0 million, respectively, for environmental remediation at our operating sites. The amounts in 2012 will be spent in years beyond second quarter 2012. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(9) Amounts include voluntary contributions to our U.S. defined benefit plan of $28.0 million and $36.0 million, respectively.

*Cash required by operating activities of discontinued operations was $20.9 million and $19.2 million for the six months ended June 30, 2012 and 2011, respectively.*

This change was primarily due to an increase in legal spending partially offset by a decrease in environmental spending related to discontinued operations in the six months ended June 30, 2012, compared to the prior year period.

*Cash required by investing activities was $199.0 million and $78.9 million for the six months ended June 30, 2012 and 2011, respectively.*

The increase in spending during the six months ended June 30, 2012, as compared to the same period in 2011 was primarily due to the payment associated with our acquisition completed in the second quarter of 2012 and increased capital expenditures associated with capacity expansions. See Note 3 to our condensed consolidated financial statements within this Form 10-Q for more detail on acquisitions.

*Cash required by financing activities was $130.9 million and $41.8 million for the six months ended June 30, 2012 and 2011, respectively.*

This increase is primarily due to higher repurchases of common stock partially offset by an increase in our borrowings under our committed credit facility.

### Other potential liquidity needs

Our cash needs for 2012 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations and borrowings under our committed revolving credit facility.

Projected 2012 capital expenditures are expected to be approximately 30 percent higher than 2011 levels, primarily to increase capacity in BioPolymer, lithium and soda ash.

Projected 2012 spending includes approximately $35 million of net environmental remediation spending. Also, we expect to spend approximately $30 million in 2012 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through June 30, 2012 of $28.0 million and intend to contribute a total of approximately $65 million in 2012. These contributions are in excess of the minimum requirements. We made voluntary contributions of $55.0 million in 2011. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

On July 19, 2012, we paid dividends totaling $12.4 million to our shareholders of record as of June 29, 2012. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of June 30, 2012. For the six months ended June 30, 2012 and 2011, we paid $22.9 million and $19.8 million, respectively.

On February 17, 2012, the Board authorized the repurchase of up to an additional $250 million of our common stock. At June 30, 2012, $244.8 million remained unused under the Board-authorized repurchase program. The repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. During the six months ended June 30, 2012, 3,072,540 shares were repurchased under the publicly announced repurchase program for $144.9 million.

The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") was signed into law. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe they will not adversely affect our liquidity in a material way.

### Commitments and Contingencies

See Note 17 to our condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2011 can be found in a table included within Part II, Item 7 of our 2011 consolidated financial statements on our 2011 10-K. There have been no significant changes to our contractual commitments during the six months ended June 30, 2012.

### Climate Change

A detailed discussion on climate change can be found in Part II, Item 7 of our 2011 consolidated financial statements on our 2011 10-K. There have been no material changes to climate change from the information reported therein.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 16 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At June 30, 2012, our financial instrument position was a net liability of $6.2 million compared to a net liability of $5.9 million at December 31, 2011. The change in the net financial instrument position was primarily due to lower unrealized losses in our commodity and foreign exchange portfolios.

### Commodity Price Risk

Energy costs are approximately nine percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at June 30, 2012 and December 31, 2011, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $3.3 million at June 30, 2012, compared to a $2.5 million decrease of the net liability position at December 31, 2011. A 10 percent decrease in energy market prices would result in an increase of $3.3 million in the net liability position at June 30, 2012, compared to an increase of $2.5 million of the net liability position at December 31, 2011.

Our Agricultural Products segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of June 30, 2012 and December 31, 2011 our net financial instrument position was immaterial.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at June 30, 2012 and December 31, 2011, with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in an increase of $7.6 million in the net liability position at June 30, 2012, compared to an increase of $2.4 million in the net asset position at December 31, 2011. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in a decrease of $5.9 million in the net liability position at June 30, 2012, compared to a decrease of $2.1 million in the net asset position at December 31, 2011. As a result, the net liability position would have become a net asset position at June 30, 2012, whereas at December 31, 2011 the net asset position would have become a net liability position.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of June 30, 2012 and December 31, 2011, we had no interest rate swap agreements.

Our debt portfolio, at June 30, 2012, is composed of 91 percent fixed-rate debt and nine percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our 2011 credit agreement, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at June 30, 2012, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $0.4 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $0.3 million for the first six months of 2012.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,623 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended June 30, 2012, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of June 30, 2012, the related condensed consolidated statements of income for the three-month and six-month periods ended June 30, 2012 and 2011, the related condensed consolidated statements of comprehensive income for the three-month and six-month periods ended June 30, 2012 and 2011, and the related condensed consolidated statements of cash flows for the six-month periods ended June 30, 2012 and 2011. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2011, and the related consolidated statements of income, cash flows, changes in equity and comprehensive income for the year then ended (not presented herein); and in our report dated February 20, 2012, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2011, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

August 1, 2012

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2011 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed Aug 1, 2012.
Source: SEC EDGAR, the filing index for accession 0000037785-12-000019. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
